Nicholas Investment Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Nicholas Investment Partners’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-37,524	Closed	-$4.32M	–	241
2019 Q3	$4.32M	Buy	37,524 +4,282	+13%	+$650K	0.36%	109
2019 Q2	$5.73M	Buy	33,242 +9,491	+40%	+$1.64M	0.53%	63
2019 Q1	$4M	Buy	23,751 +9,768	+70%	+$1.45M	0.36%	94
2018 Q4	$1.36M	Buy	+13,983	New	+$1.83M	0.15%	192
2017 Q2	–	Sell	-7,306	Closed	-$884K	–	286
2017 Q1	$884K	Sell	7,306 -64	-0.9%	-$7.85K	0.06%	240
2016 Q4	$823K	Sell	7,370 -3,854	-34%	-$464K	0.06%	258
2016 Q3	$1.49M	Buy	11,224 +3,519	+46%	+$336K	0.1%	273
2016 Q2	$706K	Buy	+7,705	New	+$649K	0.05%	289

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MGIM

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nicholas Investment Partners's GWPH Position: Q4 2019 in Review

Nicholas Investment Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2019, closing a stake of 37,524 shares — an estimated $4.32M sold.

Nicholas Investment Partners first reported a position in GWPH in Q2 2016 and held it in 8 quarters. The position peaked at $5.73M in Q2 2019. 318 funds tracked by Wall St. Rank hold GWPH as of Q4 2019.

Nicholas Investment Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2019 after selling out during the quarter.
Nicholas Investment Partners sold 37,524 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2019, an estimated $4.32M.
Nicholas Investment Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2016 and held it in 8 quarters.
Nicholas Investment Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $5.73M in Q2 2019.
318 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2019.

Based on Nicholas Investment Partners's 13F filing for Q4 2019, filed 13 Feb 2020.